Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Brain : a Journal of Neurology|February 2, 2023
Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind studyHana Florian, Deli Wang, Steven E Arnold, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 3, 2025
A proof-of-concept study of pitolisant for excessive daytime sleepiness in patients with Prader-Willi syndromeAmee Revana, Rakesh Bhattacharjee, Jennifer L Miller, et al.Current Opinion in Pharmacology|February 26, 2014
New applications of disease genetics and pharmacogenetics to drug developmentAllen D Roses, Ann M Saunders, Michael W Lutz, et al.The Lancet. Neurology|February 20, 2021
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialGünter U Höglinger, Irene Litvan, Nuno Mendonca, et al.Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
Characterization of APOE and TOMM40 allele frequencies in the Japanese populationAkira Nishimura, Hidenori Nonomura, Shingo Tanaka, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 12, 2020
Advancing combination therapy for Alzheimer's diseaseStephen P Salloway, Jeff Sevingy, Kumar Budur, et al.Journal of Neurodevelopmental Disorders|November 19, 2025
Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension studyElizabeth Berry-Kravis, Randi Hagerman, Jonathan Cohen, et al.Alzheimer'S & Dementia (New York, N. Y.)|August 11, 2018
TOMMORROW neuropsychological battery: German language validation and normative studyHeather R Romero, Andreas U Monsch, Kathleen M Hayden, et al.The Lancet. Neurology|November 19, 2022
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialMichael J Soileau, Jason Aldred, Kumar Budur, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Measuring cognition and function in the preclinical stage of Alzheimer's diseaseSandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, et al.Pageof 4